$RIGL..$3.00..was granted Orphan drug designation by the FDA for their main Ph3 candidate. No company PR yet (mentioned by @biorunup) http://1.usa.gov/1PCSbbA
-I spoke to the company yesterday & their main IR contact is on vacation. I suspect that they will issue a PR next week. Could be good for the stock price.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.